Issue Ebookcover storyIssue CoverIssue Contents
Online FirstList of IssuesDocument Types
- Abstract：Perioperative management， especially the selection and implementation of anesthesia protocols， is increasingly regarded as a potentially modifiable factor affecting long-term postoperative outcomes in tumor patients. This paper systematically discusses the key pathophysiological mechanisms in the perioperative period that influence tumor outcomes， including inflammation and immunosuppression caused by surgical trauma， physiological stress responses， and subsequent changes in the tumor microenvironment， which create opportunities for tumor cell escape and progression. It focuses on the potential effects of different types of anesthetics （sedative-hypnotics， inhaled anesthetics， local anesthetics， analgesics） on the biological behaviors of tumors （such as proliferation， invasion， metastasis， and immune response） as well as their possible molecular mechanisms. Meanwhile， this paper reviews current clinical research evidence on the impact of anesthesia modality selection and specific anesthesia management strategies on the prognosis of tumor patients. Although existing clinical evidence is insufficient to establish standardized perioperative anesthesia protocols that can significantly improve tumor prognosis， both basic and clinical studies strongly suggest that optimizing perioperative management （including the selection of anesthetics， the application of anesthesia techniques， and comprehensive supportive measures） has the potential to influence tumor outcomes by multi-dimensionally regulating the stress-inflammation-immune axis and the tumor microenvironment. Future research should focus on further clarifying the relevant mechanisms and conducting high-quality prospective clinical trials， so as to promote the establishment of evidence-based， precise and individualized perioperative management strategies for tumor patients， and ultimately improve long-term patient survival.Keywords： perioperative management;anesthetic drugs;stress modulation;immune remodeling;oncologic outcomes;immunosuppression;clinical evidence;precision medicine261|322|0<HTML><L-PDF> <Meta-XML>Updated：2026-07-20
- Abstract：ObjectiveTo investigate the association between perioperative troponin elevation and the occurrence of major adverse cardiac events （MACE） in elderly patients with colorectal cancer， and to provide evidence for optimizing perioperative management strategies.MethodsA total of 268 elderly patients aged 70 years and above who underwent colorectal cancer surgery were retrospectively enrolled. They were divided into a conventional management group （87 cases） and a standardized management group （181 cases） according to the perioperative management strategy. Binary logistic regression analysis was used to identify the independent influencing factors for the occurrence of major adverse cardiac events. P-value ≤ 0.05 was considered statistically significant.ResultsAmong the 268 patients， the overall incidence of perioperative major adverse cardiac events was 4.5% （12/268）. The total incidence of major adverse cardiac events in the conventional management group was 8.0% （7/87）， which was significantly higher than that in the standardized management group （2.8%， 5/181；P=0.05）. Specifically， the incidences of myocardial infarction， heart failure， and death in the conventional management group were markedly higher than those in the standardized management group （8.0% vs. 2.2%， 4.6% vs. 0.6%， 4.6% vs. 0.6%， all P＜0.05）， while no significant difference was observed in the incidence of cardiogenic shock between the two groups （1.1% vs. 1.1%， P＞0.05）. Postoperative troponin elevation was significantly associated with the occurrence of perioperative major adverse cardiac events except for cardiogenic shock （including total cardiovascular events， myocardial infarction， heart failure， and death） （all P＜0.05）， and it was identified as a strong independent risk factor for perioperative major adverse cardiac events in these patients.ConclusionCompared with conventional management， standardized perioperative troponin management can significantly reduce the risks of myocardial infarction， heart failure， and death， and also exhibits a potential protective trend against cardiogenic shock. Postoperative troponin elevation is a strong independent risk factor for the occurrence of perioperative major adverse cardiac events.Keywords：elderly colorectal cancer;perioperative period;troponin;major adverse cardiac events;risk management132|96|0<HTML><L-PDF> <Meta-XML>Updated：2026-07-20
- Abstract：ObjectiveThis study aimed to investigate whether dexmedetomidine （Dex） alleviates stress-induced mammary tumor progression in mice by inhibiting the TLR4/NF‑κB signaling pathway， and to examine its effects on anxiety‑depression‑like behaviors and stress hormone levels.MethodsAn orthotopic EMT6 mammary tumor model was established in mice， and chronic mild stress （CMS） was applied to induce anxiety‑depression‑like states. The mice were divided into six groups： naive， tumor， CMS， CMS+tumor， CMS+tumor+Dex， and CMS+tumor+Vehicle groups. Behavioral changes were evaluated using the open field test and tail suspension test. Plasma stress hormone levels were measured by high‑performance liquid chromatography. Western blot and RT‑qPCR were performed to detect the expression of TLR4， p‑NF‑κB p65， p‑IκBα， and inflammatory cytokines （IL‑6， IL‑1β， TNF‑α） in tumor tissues. In vitro， EMT6 cells were treated with cortisol to mimic the stress-related microenvironment， and the effects of Dex on the TLR4/NF‑κB pathway were assessed by CCK‑8， Western blot， and RT-qPCR.ResultsTumor‑bearing mice exhibited significant anxiety‑depression‑like behaviors （P＜0.05）， along with markedly elevated plasma levels of norepinephrine， epinephrine， and cortisol （P＜0.05）. Chronic stress further aggravated these behavioral abnormalities and promoted tumor growth （P＜0.05）. Dexmedetomidine intervention significantly improved anxiety‑depression‑like behaviors （P＜0.05） and lowered peripheral stress hormone levels （P＜0.05） in stress‑exposed tumor‑bearing mice. In vitro experiments demonstrated that cortisol treatment activated the TLR4/NF‑κB pathway （P＜0.001） and upregulated the expression of inflammatory cytokines （P＜0.05 in EMT6 cells， whereas dexmedetomidine effectively suppressed this activation （P＜0.001）. In the in vivo model， dexmedetomidine treatment downregulated the expression of TLR4， p‑NF‑κB p65， p‑IκBα， and pro‑inflammatory cytokines in tumor tissues （P＜0.001） and significantly inhibited tumor growth （P＜0.05）.ConclusionDexmedetomidine inhibits the TLR4/NF‑κB signaling pathway， alleviates stress‑induced inflammatory responses， improves anxiety- and depression‑ like behaviors， reduces stress hormone levels， and suppresses mammary tumor progression. These findings provide an experimental basis for understanding anxiety- and depression- associated breast tumor progression and suggest that Dexmedetomidine and the TLR4/NF-κB pathway may serve as potential therapeutic targets.Keywords：dexmedetomidine;TLR4/NF‑κB pathway;stress;mammary tumor;anxiety‑ and depression‑like behavior153|169|0<HTML><L-PDF> <Meta-XML>Updated：2026-07-20
Academic Frontiers\：Anesthesia and Oncology
- Abstract：Immune checkpoint inhibitors （ICIs） restore and enhance anti-tumor immune responses by relieving the suppressive regulatory mechanisms of the immune system， representing a landmark breakthrough in oncology that has fundamentally transformed the therapeutic paradigms for multiple malignancies and significantly prolonged survival in a subset of patients. However， clinical practice has revealed that the majority of patients develop primary resistance （initial non-response to therapy） or acquired resistance （resistance emerging after initial disease control） to ICIs treatment， substantially limiting their broad clinical application. The emergence of ICIs-resistant phenotypes may arise from diverse biological mechanisms， with complex and multifaceted resistance mechanisms encompassing alterations in tumor cell-intrinsic characteristics， tumor microenvironment （TME） remodeling， and host immune system status. In-depth investigation into ICIs resistance mechanisms and comprehensive understanding of these processes are essential for developing targeted resistance-overcoming strategies and improving the efficacy of cancer immunotherapy， which hold significant clinical implications and broad application prospects. This review provides a focused overview of ICIs resistance mechanisms with a summary of research advances in resistance-overcoming strategies. Resistance mechanisms include tumor cell-intrinsic factors， tumor microenvironmental factors， immune evasion-related mechanisms， and drug-related factors while resistance-overcoming strategies encompass combination therapies， novel target drug development， and tumor microenvironment modulation. With the understanding we aim to establish a theoretical foundation for enhancing ICIs therapeutic efficacy.Keywords：tumors;immune checkpoint inhibitors;drug resistance mechanisms;tumor microenvironment;combination therapy168|186|0<HTML><L-PDF> <Meta-XML>Updated：2026-07-20
Invited Review
- Abstract：Benign-malignant differentiation and risk stratification of pulmonary nodules are critical issues in lung cancer screening and clinical management. Conventional assessment mainly relies on imaging evaluation， dynamic follow-up， and pathological confirmation， but its diagnostic performance remains limited in clinical scenarios involving small nodules， ground-glass nodules， and inflammatory lesions. In recent years， advances in radiomics， genomics， transcriptomics， proteomics， metabolomics， and microbiomics have provided multi-level biological evidence for the precise evaluation of pulmonary nodules from the perspectives of imaging phenotype， genetic variation， molecular expression， functional status， metabolic reprogramming， and host-microbe interaction. Compared with single-omics approaches， multi-omics integration， through cross-level information fusion， enables a more comprehensive characterization of the biological heterogeneity of pulmonary nodules and further improves the performance of benign-malignant differentiation and risk stratification. Relevant studies showed that the area under the curve （AUC） increased from 0.80-0.87 to 0.93. This review systematically summarizes recent advances in multi-omics research for benign-malignant differentiation and risk stratification of pulmonary nodules， with a focus on their value in biomarker discovery， risk assessment， and clinical decision support. Current challenges， including lack of standardization， insufficient external validation， and barriers to clinical translation， are also discussed to provide references for future research on precision management of pulmonary nodules.Keywords：pulmonary nodules;multi-omics;benign and malignant differentiation;risk stratification;precision assessment94|58|0<HTML><L-PDF> <Meta-XML>Updated：2026-07-20
- Abstract：Bowel sounds are important acoustic physiological signals that reflect gastrointestinal motility and have significant clinical value in the evaluation of postoperative ileus， intestinal obstruction， and inflammatory bowel diseases. Conventional auscultation is highly subjective and often irreproducible， making continuous and objective monitoring difficult. With advances in microelectronics and signal processing technologies， wearable devices have enabled long-term， dynamic， and noninvasive acquisition of bowel sound signals. Meanwhile， ecological momentary assessment （EMA）， characterized by real-time and repeated data collection of individual behaviors and physiological states in realistic situations， provides a novel methodological framework to overcome the limitations of momentary bowel sound monitoring and to facilitate context-based interpretation. This review systematically summarizes the development of wearable bowel sound monitoring technologies， outlining three stages of the technological evolution stationary acquisition， dedicated portable systems， and wearable long-term monitoring. The clinical application value of bowel sound monitoring in multiple scenarios， including irritable bowel syndrome and inflammatory bowel diseases， is also discussed. Furthermore， the theoretical framework of EMA is introduced for the first time in the field of bowel sound monitoring， and its potential value， application scenarios， and methodological challenges are explored. The integration of wearable technology with the EMA framework may provide a theoretical basis for constructing an，individualized long-term gastrointestinal motility monitoring system with high ecological validity， to optimize postoperative care， improve home management of chronic gastrointestinal diseases， and advance precision health monitoring. Future efforts should focus on key issues such as equipment standardization， clinical validation， and algorithmic interpretability to accelerate progress in this field.Keywords：bowel sounds;ecological momentary assessment;wearable devices;gastrointestinal motility;precision health monitoring78|41|0<HTML><L-PDF> <Meta-XML>Updated：2026-07-20
Review
- Abstract：ObjectiveTo explore the effects of electroacupuncture at governor vessel or Jiaji acupoints on the activation of lumbar spinal cord neurons and the recovery of motor function in paralyzed hind limbs in rats with complete transection of spinal cord injury.MethodsTwenty adult female SD rats were selected. Among them， 15 rats underwent the complete transection of the 10th thoracic spinal cord and were randomly divided into the Control group， the electroacupuncture at governor vessel acupoints （GV） group and the electroacupuncture at Jiaji acupoints （JJ） group， with 5 rats in each group. The other 5 rats served as the Normal group. Electroacupuncture treatment was initiated 3 days after surgery in the GV and JJ groups and performed every other day. Basso-Beatti-Bresnahan （BBB） behavioral score was evaluated weekly. Eight weeks after the operation， cortical motor evoked potential （CMEP） detection was performed， followed by perfusion fixation， tissue harvest， frozen sectioning， and immunofluorescence staining experiments.Results① Both electroacupuncture treatments activated the expression of the excitatory marker c-Fos in L1 spinal cord neurons. The c-Fos+ activated neurons were mainly distributed in lamina Ⅳ， Ⅴ and Ⅶ of the L1 spinal cord， while no c-Fos+ neuron was observed in the Normal group and the Control group. The percentages of c-Fos+ neurons activated by electroacupuncture in the GV group and the JJ group were （10.23±0.15） % and （10.77±1.12） %， respectively， and there was no significant difference between the two electroacupuncture groups. ② vGluT1+ proprioceptive afferent nerve fibers were mainly distributed in the dorsal horn and lamina Ⅶ of intermediate zone of L1 spinal cord gray matter. In the dorsal horn of L1 spinal cord， the relative fluorescence intensity of vGluT1+ nerve fibers in the GV group and the JJ group were greater than that in the Control group， and that in the JJ group was greater than that in the GV group. In the lamina Ⅶ in intermediate zone of L1 spinal cord， where the central pattern generator （CPG） for hindlimb rhythmic movement is located， the relative fluorescence intensity of vGluT1+ nerve fibers in the GV group and the JJ group were significantly higher than that in the Control group， and the JJ group was also higher than the GV group； The lamina Ⅶ neurons innervated by vGluT1+ axon terminals were activated to express the excitatory marker c-Fos in the GV group and the JJ group. ③ The immunofluorescence staining results of acetylcholinesterase （ChAT） in the ventral horn of L4 spinal cord of each group showed that the number of surviving ChAT+ motor neurons in the GV group （19.1±3.4， P=0.000 2） and JJ group （19.0±2.9， P=0.000 2） were higher than that in the Control group （9.9±1.9）. ④ The quantitative analysis of the vGluT2+ excitatory axonal terminals， vGAT+ inhibitory axonal terminals， and the ratio of vGluT2+/vGAT+ axonal terminals ［reflecting the excitation/inhibition （E/I） balance of motor neurons］ innervating ChAT+ motor neurons in the ventral horn of the L4 spinal cord revealed that all three indices were significantly higher in the GV and JJ groups than in the Control group. Moreover， the E/I ratio of motor neurons in the two electroacupuncture groups gradually reached the same level as normal and showed no statistical difference from the Normal group. ⑤ The electrophysiological and behavioral detection results showed that compared with the Control group， the latencies of CMEP in the GV group and the JJ group shortened， while their amplitudes increased. The BBB score of paralyzed hindlimbs showed that after 8 weeks of treatment， the scores of both the GV group （4.25±1.26， P=0.023 4） and the JJ group （4.75±0.96， P=0.000 2） were higher than those of the Control group （1.80±1.30）， but there was no statistical difference between the two electroacupuncture groups.ConclusionElectroacupuncture at GV or JJ acupoints may promote the afferent of vGluT1+ proprioceptive nerve fibers into the spinal cord， indicating the possibility to activate CPG neurons in lamina Ⅶ of L1 spinal cord； facilitate the survival of motor neurons in the L4 spinal cord and restore their excitatory/inhibitory balance， improving the motor function of the paralyzed hindlimbs in rats.Keywords：spinal cord injury;electroacupuncture;governor vessel acupoints;Jiaji acupoints;motor function86|53|0<HTML><L-PDF> <Meta-XML>Updated：2026-07-20
- Abstract：ObjectiveTo investigate whether photoreceptor-specific knockout of lanosterol synthase （Lss） induces age-related retinal degeneration and to elucidate the underlying molecular mechanisms.MethodsPhotoreceptor-specific Lss knockout mice （Lssflox/flox； Rho-Cre， CKO） models were established. Retinal structure and function were assessed at 1， 4， and 8 months of age using fundus photography， optical coherence tomography （OCT）， scotopic electroretinogram （ERG） and hematoxylin and eosin （HE） staining. The mouse photoreceptor cell line 661W served as an in vitro model. Lss was knocked down via siRNA， followed by analyses including Seahorse XF mitochondrial stress test， JC-1， MitoSOX Red and DCFH-DA probes to evaluate mitochondrial function and oxidative stress， glycolytic rate assay for glycolysis ability， RT-qPCR for inflammatory factors， γH2AX immunofluorescence for double-strand DNA damage detection， and transcriptome sequencing to identify differentially expressed genes and enriched pathways.ResultsCompared with controls， 1-month-old CKO mice showed no abnormalities. Mild fundus lesions appeared at 4 months. By 8 months， CKO mice exhibited significant thinning of the outer nuclear layer， disorganization of the inner/outer segment structure， and markedly reduced amplitudes of the dark-adapted ERG a- and b-waves （P<0.05）. Transcriptome analysis revealed 1 842 differentially expressed genes （826 up-regulated， 1 016 down-regulated）， with Lss being the most significantly downregulated gene； these genes significantly enriched in sterol biosynthesis， oxidative phosphorylation， aerobic electron transport chain， and ATP synthesis （P<0.05）. In 661W cells， knockdown of Lss significantly reduced mitochondrial basal respiration （P=0.006）， ATP production （P=0.015）， maximal respiration （P<0.001）， and spare respiratory capacity （P<0.001）， while basal glycolysis （P=0.005） and compensatory glycolysis （P=0.028） were increased. These changes were accompanied by mitochondrial membrane potential depolarization （P<0.001）， elevated mitochondrial reactive oxygen species （ROS） levels （P<0.001）， and increased total ROS levels （P=0.013）. Additionally， the mRNA expression of inflammatory factors， including Ccl2 （P=0.004）， Ccl5 （P=0.012）， Cxcl1 （P<0.001）， Cxcl5 （P<0.000 1）， Tgfb （P=0.008）， Hgf （P<0.000 1） and Mmp3 （P=0.003） was significantly upregulated. Moreover， γH2AX fluorescence intensity was increased （P=0.002）.ConclusionsPhotoreceptor-specific Lss deficiency induces mitochondrial dysfunction， oxidative stress and cellular inflammation， ultimately leading to age-dependent retinal degeneration. This study provides novel mechanistic insights and potential therapeutic targets for hereditary and age-related retinal degenerative diseases.Keywords：lanosterol synthase;photoreceptor;retinal degeneration;mitochondrial dysfunction;oxidative stress78|48|0<HTML><L-PDF> <Meta-XML>Updated：2026-07-20
- Abstract：ObjectiveTo elucidate the expression patterns of CYHR1 in colorectal cancer （CRC） and its regulatory role in tumour cell proliferation and metastasis-related phenotypes.MethodsExpression differences of CYHR1 between colorectal cancer tissues and adjacent normal tissues were analyzed using data from The Cancer Genome Atlas （TCGA） database， and the association between CYHR1 expression and patient survival was evaluated. A CRC cell model with CYHR1 overexpression was established， and changes in the expression of related molecules were verified by quantitative real-time PCR （qRT-PCR）. Cell proliferation and metastatic potential were assessed using MTT assays， colony formation assays， and Transwell migration and invasion assays to evaluate the effects of CYHR1 and MALAT1 on CRC cell proliferation and migration/invasion， including combined intervention experiments.ResultsDatabase analysis revealed that CYHR1 is significantly overexpressed in CRC tissues， and that this overexpression is significantly associated with poorer overall survival. Compared with normal control cells， mRNA expression levels of CYHR1 were markedly elevated in CRC cell lines （HCT116， RKO， etc.） （P=0.002； P=0.006）. Functional experiments demonstrated that CYHR1 overexpression significantly promoted the proliferation （P＜0.001）， colony formation （P＜0.001）， migration （P=0.002） and invasive capacity （P=0.002） of HCT116 cells； whereas knockdown of either CYHR1 or MALAT1 inhibited CRC cell proliferation and reduced their migration （P=0.006） and invasive capacity （P=0.006）. In the context of CYHR1 overexpression， combined knockdown of MALAT1 partially reversed the promotional effect of CYHR1 on CRC cell proliferation， migration and invasion （P＜0.001； P=0.001）. Mechanistic studies further revealed that CYHR1 overexpression upregulates MALAT1 mRNA expression levels （P＜0.001）， whilst CYHR1 knockdown leads to downregulation of MALAT1 expression （P＜0.001）； MALAT1 knockdown likewise downregulates CYHR1 expression， suggesting a mutually reinforcing positive regulatory relationship between the two. Furthermore， CYHR1 can activate the IL-6/STAT3 signalling axis， whilst knockdown of IL-6 or STAT3 inhibited the upregulation of MALAT1 expression by CYHR1 （P=0.031； P=0.006）.ConclusionCYHR1 is abnormally overexpressed in colorectal cancer and is closely associated with poor prognosis. CYHR1 may promote the proliferation， migration， and invasion of colorectal cancer （CRC） cells by activating the IL-6/STAT3/MALAT1 axis.Keywords：colorectal cancer;cysteine/histidine-rich 1;metastasis-associated lung adenocarcinoma transcript 1;proliferation;migration;invasion83|58|0<HTML><L-PDF> <Meta-XML>Updated：2026-07-20
- Abstract：ObjectiveTo investigate the molecular mechanisms by which the receptor for advanced glycation end products（RAGE）-signal transducer and activator of transcription 3（STAT3） signaling pathway mediates mitochondrial injury in striosome/matrix compartment neurons under dopaminergic depletion in Parkinson's disease （PD）.MethodsA 6-hydroxydopamine （6-OHDA）-induced rat model of PD was established and treated with the RAGE inhibitor FPS-ZM1. Immunohistochemistry， double immunofluorescence staining， transmission electron microscopy （TEM）， Western blotting， and quantitative real-time PCR （qRT-PCR） were performed to evaluate RAGE and STAT3 expression as well as mitochondrial ultrastructure alterations in the striosome/matrix compartment.ResultsThe density of RAGE-positive structures and the protein expression level of RAGE in the striosome/matrix compartment were significantly increased in PD rats compared with controls （P<0.05）. Immunohistochemical and double immunofluorescence analyses demonstrated widespread STAT3 expression in striatal neurons， while the number of NeuN/STAT3 double-positive cells was significantly elevated in the PD group （P<0.05）. Western blotting and qRT-PCR further confirmed significant upregulation of STAT3 protein and mRNA expression in PD rats （P<0.05）. TEM analysis revealed marked mitochondrial abnormalities in PD neurons， including reduced mitochondrial density， enlarged mitochondrial area， decreased cristae number， cristae membrane disruption， and outer membrane damage （all P<0.05）. Notably， FPS-ZM1 treatment partially reversed these mitochondrial ultrastructural alterations.ConclusionActivation of the RAGE-STAT3 signaling pathway contributes to mitochondrial structural disruption in striosome/matrix compartment neurons in PD. These findings suggest that the striosome/matrix compartment may represent a novel pathological target for investigating mitochondrial dysfunction and neurodegeneration in PD.Keywords：Parkinson's disease;receptor for advanced glycation end products;signal transducer and activator of transcription 3;striosomes;mitochondria;dopamine83|43|0<HTML><L-PDF> <Meta-XML>Updated：2026-07-20
- Abstract：ObjectiveTo investigate the inhibitory effect of tauroursodeoxycholic acid （TUDCA） on neurogenic heterotopic ossification （NHO） after spinal cord injury and its potential mechanism.MethodsSPF-grade male C57BL/6 mice were used to establish an NHO model. The mice were randomly divided into three groups： sham operation group （laminectomy only）， NHO model group （spinal cord injury + intramuscular injection of cardiotoxin）， and TUDCA treatment group （NHO model + daily intragastric administration of TUDCA at 200 mg/kg for 4 consecutive weeks）. The area and maturity of heterotopic ossification were quantitatively assessed by micro-computed tomography（micro-CT） and hematoxylin-eosin（H&E） staining. Flow cytometry was used to quantify the interleukin（IL）-1β secretion level of M2 macrophages. RAW264.7 macrophages were cultured in vitro and divided into control， tumor necrosis factor（TNF）α， and TNFα+TUDCA （200 μmol/L） groups to detect the expression level of the polarization marker CD206. Additionally， macrophages were divided into control， TUDCA 200 μmol/L， and TUDCA 400 μmol/L groups to assess the IL-1β secretion level.ResultsCompared with the NHO group， the bone volume in the TUDCA-treated group was significantly reduced （12.69±1.13 vs. 7.647±1.19， P=0.003）. Compared with the TNFα group， qPCR results showed that the expression of the M2 macrophage marker CD206 was significantly upregulated in the TNFα+TUDCA group （0.55±0.019，1.11±0.023， P＜0.001）. Compared with the control group， ELISA results showed that TUDCA stimulation of macrophages significantly upregulated IL-1β secretion （404.7±24.38 vs. 652.8±32.61， P=0.003 7）. TUDCA administration upregulated IL-1β secretion by local muscle macrophages and inhibited heterotopic ossification formation.ConclusionsTUDCA might participate in inhibiting NHO formation by inducing M2 macrophage polarization and upregulating IL-1β secretion， thereby alleviating the development and progression of neurogenic heterotopic ossification after spinal cord injury. This finding provides experimental evidence for expanding the application of TUDCA in the treatment of complications following spinal cord injury.Keywords：neurogenic heterotopic ossification;spinal cord injury;tauroursodeoxycholic acid;M2 macrophage;interleukin-1β68|41|0<HTML><L-PDF> <Meta-XML>Updated：2026-07-20
Preclinic Research
- Abstract：ObjectiveTo explore the relationship between triglyceride high-density cholesterol-glucose body index （TyHGB） and gestational diabetes mellitus （GDM）.MethodsThis single-center retrospective cohort study was conducted. A total of 723 singleton pregnant women who received prenatal care and delivered at Lingnan Hospital， the Third Affiliated Hospital of Sun Yat-sen University， from May 2024 to July 2024 were enrolled. Clinical baseline data and laboratory test results in the first trimester （before 13+6 weeks of gestation） were collected. Based on the tertiles of the TyHGB index were equally divided into 3 groups. Clinical baseline data， and GDM risk were compared among the three groups.ResultsCompared with the control group， the GDM group had older maternal age， higher Pre-pregnancy BMI， FPG， TG， and higher values of 75 g OGTT fasting plasma glucose， 1 h plasma glucose， and 2 h plasma glucose. The early-pregnancy TyHGB index， andincidence of macrosomiawere all higher in the GDM group than in the control group （ all P<0.05）， whereas gestational weight gain （GWG） was lower than that of the control group （P<0.05）. The individuals were divided into three groups according to the tertiles of the TyHGB index. Significantly differences were identified among TyHGB index tertiles in maternal age， parity， Pre-BMI， FPG， TC， TG， HDL-C， LDLL-C， Ur， 75 g OGTT fasting plasma glucose， 1 h plasma glucose， 2 h plasma glucose， GWG， neonatal birth weight， GDM， GH， macrosomia incidence， and cesarean section rate（all P<0.05）. Further trend test analysis found that matenal age， parity， Pre-BMI， FPG， TC， TG， LDL-C， 75 g OGTT_FPG， 75 g OGTT_1 h PG and 75 g OGTT_2 h PG level， neonatal birth weight， GDM， GH， incidence of macrosomia and cesarean section rate all showed an upward trend. The multivariate Logistic regression models revealed that there was an independent positive correlation between TyHGB index and the risk of GDM. Curve fitting by restricted cubic splines （RCS） were used to assess linearity between TyHGB and GDM， and there was a linear dose-response relationship between TyHGB and GDM （P nonlinear test = 0.597）. The threshold value for early pregnancy TyHGB index to predict GDM was 6.449 ， with an area under the curve （AUC） of 0.644 （95% CI： 0.597-0.691）， sensitivity of 0.480 ， and specificity of 0.779. After adjusting for maternal age， Pre-BMI， family history of diabetes， and history of GDM， the AUC for the early pregnancy TyHGB index to predict GDM was 0.672 （95% CI： 0.626-0.718）.ConclusionThe early-pregnancy TyHGB index is independently associated with GDM risk， and exhibits a linear dose-response relationship with GDM. It may serve as an early screening and monitoring tool for pregnant women at high risk of GDM. However， its predictive value for GDM requires further validation.Keywords：singleton pregnancy;first trimester;triglyceride high-density cholesterol-glucose body index;gestational diabetes mellitus;prediction100|69|0<HTML><L-PDF> <Meta-XML>Updated：2026-07-20
- Abstract：ObjectiveThis study aimed to evaluate the myocardial mechanical characteristics in patients with Brugada syndrome （BrS） using multimodal echocardiography， to provide imaging evidence for the assessment of occult myocardial mechanical abnormalities in BrS.MethodsPatients diagnosed with BrS in Sun Yat-sen Memorial Hospital between January 2020 and December 2023 were enrolled. Speckle-tracking echocardiography （STE） was performed to measure left ventricular global longitudinal strain （LV-GLS）， right ventricular free wall longitudinal strain （RVFW-LS）， and right ventricular global longitudinal strain （RV-GLS）， as well as corresponding mechanical dispersion parameters （LV-MD， RVFW-MD， RV-MD）. Left and right ventricular myocardial performance indices （LV-MPI， RV-MPI） were calculated using tissue Doppler imaging （TDI）.ResultsAll five BrS patients had normal conventional ventricular systolic function， while marked individual differences were observed in multimodal echocardiographic parameters. Patients with high-risk phenotype， characterized by both spontaneous type 1 Brugada electrocardiogram and SCN5A gene mutation， exhibited elevated myocardial performance indexes （maximum LV-MPI 0.53， maximum RV-MPI 0.67） or increased mechanical dispersion （maximum LV-MD 61 ms）.ConclusionPatients with BrS present subclinical myocardial mechanical dysfunction undetectable by conventional echocardiography. Combined assessment of myocardial performance index and multi-parameter STE can identify subtle impairments in ventricular function and systolic synchronicity. Multimodal echocardiography has valuable potential for the assessment of subclinical myocardial injuries in BrS.Keywords：Brugada syndrome;speckle tracking echocardiography;myocardial strain;mechanical dispersion;myocardial performance index68|46|0<HTML><L-PDF> <Meta-XML>Updated：2026-07-20
- Abstract：ObjectiveTo investigate the clinical characteristics， diagnostic challenges， and treatment strategies in pediatric patients with ureteropelvic junction obstruction （UPJO） complicated with ipsilateral ureterovesical junction obstruction （UVJO）.MethodsA retrospective analysis was conducted on clinical data of pediatric patients admitted to our hospital between January 2014 and December 2024 with a confirmed diagnosis of UPJO complicated with UVJO. The collected clinical parameters included gender， age at presentation， initial diagnosis， lesion laterality， imaging findings， surgical procedures， and follow-up outcomes.ResultsThe study cohort comprised 14 pediatric patients （male=10 and female=4） with a median age of 3.1 months at presentation. The initial diagnoses were UPJO in 9 cases and UVJO in 5 cases. Preoperatively， only 6 cased showed ureteral dilation on MRU. The definitive diagnosis was confirmed by intraoperative retrograde pyelography in 5 cases， postoperative antegrade pyelography via a nephrostomy tube in 7 patients， and combined application of the two modalities in 2 patients. For primary surgical intervention， 9 patients underwent pyelo-plasty， 2 underwent ureteral reimplantation， 2 received percutaneous nephrostomy， and 1 underwent ureteral orifice dilation. Intraoperative nephrostomy tube placement was performed in 10 patients. With a median follow-up duration of 5.5 years， 4 patients required revision surgery. Of these， only 1 patient ， who had an initial diagnosis of UPJO， required staged management for persistent obstruction， whereas UPJ obstruction resolved after ureteroneocystostomy in the remaining 3 patients with an initial diagnosis of UVJO. Among the 10 patients who did not undergo revision surgery， 8 showed delayed distal urinary drainage on APG， yet remained asymptomatic with continuous improvement of hydronephrosis after nephrostomy tube clamping.ConclusionsPreoperative diagnosis of concurrent UPJO and ipsilateral UVJO in pediatric patients is clinically challenging. Further intraoperative evaluation is mandatory when antegrade or retrograde ureteral stent placement fails during surgery. For patients with an initial diagnosis of UPJO， pyeloplasty is the first-line treatment. Routine retrograde pyelography is not recommended， whereas nephrostomy tube with subsequent postoperative APG evaluation can prevent unnecessary ureteroneocystostomy. For patients with an initial diagnosis of UVJO accompanied by severe ureteral dilation， primary ureteroneocystostomy is feasible initial management strategy.Keywords：pediatric patients;ureteropelvic junction obstruction;ureterovesical junction obstruction;hydronephrosis;surgical intervention65|40|0<HTML><L-PDF> <Meta-XML>Updated：2026-07-20
- Abstract：ObjectiveTo investigate the feasibility and efficacy of modified video-endoscopic inguinal lymphadenectomy （M-VEIL）， guided by the layer surgery concept， in reducing postoperative complications in patients with penile cancer.MethodsA retrospective analysis was conducted on 27 patients with penile cancer who underwent bilateral laparoscopic inguinal lymphadenectomy at the Affiliated Hospital of Qingdao University between March 2018 and March 2022. All patients had undergone prior penile surgery. M-VEIL followed a standardized four-step procedure guided by fascial planes to achieve compartment-oriented resection， with deep lymphatic trunks ligated by silk sutures and endoscopic compression suture of the skin to the muscle layer using 4-0 absorbable threads.ResultsPreoperative physical examinations and imaging findings revealed bilateral inguinal lymphadenopathy， and no distant metastases were detected in any patient. Among the 27 patients， 12 underwent traditional video-endoscopic inguinal lymphadenectomy （T-VEIL； mean age 61.08±12.75） years and 15 underwent M-VEIL （mean age 54.47±14.64） years. All 27 operations were successfully completed without conversion to open surgery. No significant differences were observed between the two groups in operative time， intraoperative blood loss， postoperative hospital stay， number of lymph nodes retrieved， or lymph node positivity rate （all P >0.05）. Drain removal time was significantly shorter in the M-VEIL group （15.93±6.89 days vs. 23.33±10.42 days； P＜0.05）. Lymphatic leakage （2 vs. 8 patients） and surgical site infection （1 vs. 6 patients） occurred less frequently in the M-VEIL group （both P ＜0.05）. No significant differences were found in lymphocele， flap necrosis， lymphedema， or lower limb edema between the two groups （all P >0.05）. During postoperative follow-up for 1-3 years， 2 patients developed pelvic lymph node metastases， while the remaining 25 showed no evidence of local or pelvic recurrence.ConclusionCompared with T-VEIL， M-VEIL appears to reduce postoperative complications and shorten drain removal time in patients undergoing inguinal lymphadenectomy for penile cancer， while providing favorable clinical outcomes. Preliminary evidence suggests that M-VEIL is a safe and feasible modified procedure.Keywords：penile cancer;video-endoscopic inguinal lymphadenectomy;lymph node metastasis;postoperative complications;layer surgery74|47|0<HTML><L-PDF> <Meta-XML>Updated：2026-07-20
- Abstract：ObjectiveCurrently， evidence regarding whether the left or right nostril should be preferentially selected for nasotracheal intubation （NTI） in children remains insufficient， particularly under continuous visualization conditions. This study aimed to compare the efficiency and safety of NTI via the left versus right nostril in children under flexible intubation video endoscope （FIVE） guidance.MethodsA total of 100 children aged 3-7 years with American Society of Anesthesiologists physical status I-II， who were scheduled for elective dental caries treatment under general anesthesia， were randomly assigned to undergo FIVE-guided NTI via either the left nostril （group L） or the right nostril （group R）. The primary outcome was intubation time. Secondary outcomes included first-attempt success rate， number of intubation attempts， incidence and severity of epistaxis， peri-intubation hemodynamic and respiratory parameters， and postoperative procedure-related complications （nasal blockage， sore throat， and hoarseness）.ResultsNo statistically significant between-group difference was found in intubation time （L group： 36.86 ± 6.04 s vs. R group： 37.96 ± 6.20 s； P=0.371） or first-attempt success rate （96% vs. 92%， respectively； P=0.400）. The incidence and severity of epistaxis were comparable between groups （10% vs. 12%； P=0.749）. No statistically significant between-group differences were observed in hemodynamic and respiratory parameters at all measured time points （all P>0.05）. The incidences of postoperative nasal congestion， sore throat， and hoarseness were low in both groups.ConclusionIn children undergoing FIVE-guided NTI， tracheal catheter insertion via the left or right nostril yields comparable efficacy and safety. When using visualization-guided techniques in routine pediatric clinical practice， nostril laterality does not need to be prioritized when selecting the insertion side for NTI.Keywords：nasotracheal intubation;flexible intubation video endoscope;pediatric anesthesia;epistaxis;nostril selection;airway management79|46|0<HTML><L-PDF> <Meta-XML>Updated：2026-07-20
- Abstract：ObjectiveTo analyze the clinical manifestations， diagnostic approaches， treatment strategies， and prognostic outcomes of uterine arteriovenous fistula （UAVF）.MethodsWe retrospectively analyzed 6 patients with confirmed UAVF admitted to the Department of Gynecology， the Eighth Affiliated Hospital of Sun Yat-sen University， between January 2010 and December 2023. We summarized the clinical data of the cohort， including age， gravidity， chief complaints， treatment regimens， and postoperative follow-up outcomes， and explored the clinical efficacy and safety of ultrasound-guided microwave ablation for UAVF in conjunction with a literature review.ResultsThe patients were aged 26-44 years， with a mean age of （34.33±6.12） years and a median age of 33.5 years. All patients were initially screened via color Doppler ultrasound and definitively diagnosed by imaging modalities including uterine arteriography， computed tomography， and magnetic resonance imaging. The median gravidity was 4（4，6）， with 5 patients having a history of ≥2 pregnancies. Five patients had a history of intrauterine instrumentation， among whom 4 had undergone ≥2 procedures. Regarding clinical presentations， 3 patients presented with abnormal vaginal bleeding （2 with massive hemorrhage）， 2 were asymptomatic with abnormalities detected only on imaging， and 1 reported lower abdominal pain. In terms of management， 1 patient with recurrence after uterine artery embolization （UAE） underwent ultrasound-guided microwave ablation； 1 received UAE alone； 2 patients with concomitant retained products of conception underwent hysteroscopic mechanical morcellation （1 developed massive hemorrhage 10 hours postoperatively， which was successfully controlled with uterine balloon tamponade）； 1 underwent focal lesion resection； and 1 underwent total hysterectomy. All 6 patients achieved favorable therapeutic outcomes.ConclusionAbnormal vaginal bleeding is the most typical clinical manifestation of UAVF， and digital subtraction angiography of the uterine arteries is recognized as the gold standard for definitive diagnosis. Emergency UAE is indicated for patients presenting with acute massive hemorrhage and hemodynamic instability. For patients with failed UAE or post-UAE recurrence who desire uterine and fertility preservation， ultrasound-guided microwave ablation represents a safe， effective， and novel minimally invasive therapeutic option.Keywords：uterine arteriovenous fistula;uterine artery embolization;ultrasound-guided;contrast-enhanced ultrasound;microwave ablation;treatment54|29|0<HTML><L-PDF> <Meta-XML>Updated：2026-07-20
- Abstract：ObjectiveTo investigate the incidence， glucolipid metabolism characteristics， and associated factors of postoperative overweight/obesity in children and adolescent with craniopharyngioma.MethodsA retrospective study was conducted using follow-up data from 44 patients （aged 0-18 years） diagnosed with craniopharyngioma who underwent surgical treatment and received follow-up care at Sun Yat-sen Memorial Hospital， Sun Yat-sen University， between January 2006 and February 2024. The incidence and glucolipid metabolism characteristics of overweight/obesity were summarized， and potential influencing factors were analyzed.ResultsA total of 44 patients were enrolled. The mean age at surgery was （8.57 ± 4.25） years， and the mean age at last follow-up was （16.02 ± 5.36 ）years. The mean follow-up duration was （7.45 ± 4.64） years （range， 8 months to 17.5 years）. The preoperative incidence of overweight/obesity was 40.91% （predominantly overweight， 27.27%）， which increased to 68.18% postoperatively （predominantly obesity， 50.00%）. Postoperatively， all patients （44/44， 100%） underwent fasting plasma glucose （FPG） testing， among whom 2 （4.55%） had impaired fasting glucose （IFG）. Fasting insulin （FINS） was measured in 20 patients， and insulin resistance was identified in 11 （55.00%）. Oral glucose tolerance testing （OGTT） with insulin release assessment was performed in 12 patients， and all （100%） exhibited abnormal insulin secretion， including 5 （41.67%） with hyperinsulinemia and 3 （25.00%） diagnosed with diabetes mellitus （DM）. All patients （44/44， 100%） underwent lipid profile assessment. The incidence of dyslipidemia was 81.82% （36/44）， including elevated non-high-density lipoprotein cholesterol （29/44， 65.91%）， hypertriglyceridemia （29/44， 65.91%）， low high-density lipoprotein cholesterol （22/44， 50.00%）， and mixed hyperlipidemia （13/44， 29.55%）. Logistic regression analysis indicated that preoperative overweight/obesity and postoperative abnormal glucose metabolism were significant factors associated with postoperative overweight/obesity. Compared with normal-weight patients， those with postoperative overweight/obesity had higher FINS levels （14.22 mU/L vs. 3.57 mU/L）， higher insulin resistance index（HOMA-IR） （2.88 vs. 0.52）， and a higher incidence of abnormal glucose metabolism （77.78% vs. 23.08%）. However， no significant difference was observed in the incidence of dyslipidemia （94.44% vs. 73.08%）.ConclusionsChildren and adolescent with craniopharyngioma exhibit a higher incidence of overweight/obesity than healthy peers preoperatively， which becomes more pronounced after surgery. This is accompanied by a high incidence of glucolipid metabolic disorders， placing these patients at increased risk of metabolic syndrome， which warrants clinical attention and regular metabolic assessment. In patients who develop postoperative obesity， particular attention should be given to the risk of glucose metabolism abnormalities， and further monitoring of glucose homeostasis is recommended.Keywords：children;adolescents;craniopharyngioma;overweight， obesity;glucolipid metabolism74|41|0<HTML><L-PDF> <Meta-XML>Updated：2026-07-20
- Abstract：ObjectiveTo explore the influencing factors of tumor regression patterns after neoadjuvant chemotherapy （NACT） in breast cancer， construct and validate a predictive model for tumor regression patterns.MethodsA total of 1 314 breast cancer patients who received NACT between March 1， 2019， and March 1， 2024， were selected as study subjects and randomly divided into a validation cohort （n=301） and a study cohort （n=603）. Within the study cohort， patients were further stratified based on post-NACT tumor regression patterns into a concentric regression group（case group）（n=387） and a non-concentric regression group（control group）（n=216）. General clinicopathological data were collected and compared between the two groups. Unconditional logistic regression was used to analyze the influencing factors of tumor regression patterns post-NACT and establish a predictive model. The Hosmer-Lemeshow test and receiver operating characteristic （ROC） curve were employed to evaluate the model's goodness-of-fit and predictive performance， followed by external validation.ResultsAmong all subjects in the study cohort， 174 patients （28.9%） achieved pathological complete response （pCR）， 213 （35.3%） showed unifocal regression， 92 （15.3%） had multifocal regression， 78 （12.9%） presented main residual lesions with satellite lesions， 43 （7.1%） had stable disease， and 3 （0.5%） experienced disease progression. Significant differences were observed between the two groups in age， estrogen receptor（ER）， progesterone receptor（PR）， Ki-67， human epidermal growth factor receptor 2（HER2）， histological grade， prognostic nutritional index（PNI）， and chemotherapy regimen （all P ＜ 0.05）. Logistic regression analysis revealed that age （OR=0.563， 95% CI： 0.358–0.885）， ER （OR=0.521， 95% CI： 0.350–0.773）， PR（OR=0.552， 95% CI： 0.379–0.806）， HER2（OR=3.729， 95% CI： 2.488–5.590）， Ki-67 （OR=1.804， 95% CI： 1.071–3.039）， PNI （OR=2.285， 95% CI： 1.307–3.997） and histological grade （Ⅲ） （OR=2.194 95% CI： 1.283–3.751） were independent influencing factors for concentric regression post-NACT （all P ＜ 0.05）. The Hosmer-Lemeshow test for the logistic regression model yielded a P-value of 0.927， and the area under the ROC curve was 0.731 （95%CI： 0.690-0.772， P ＜ 0.001）. External validation demonstrated that the area under the ROC curve of this prediction model was 0.764 （95% CI： 0.709–0.820， P＜0.001）， with a sensitivity of 75.0% and a specificity of 65.7%. The Youden's index was 0.407.ConclusionThis logistic regression model exhibits high predictive value and provides a reference for clinicians to predict tumor regression patterns in breast cancer patients after NACT.Keywords：breast cancer;neoadjuvant chemotherapy;tumor regression pattern;predictive model87|54|0<HTML><L-PDF> <Meta-XML>Updated：2026-07-20
Clinical Research
